Nonamer peptide structures
710 items
Page 13 of 29 | 25 items per page | ordered by release date, descending
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 295E00 |
HLA-A*02:01 binding "GVWIRTPPA" at 1.70Å resolution |
5FA3 |
HLA-A*02:01 binding "GLLPELPAV" at 1.86Å resolution |
5F9J |
HLA-A*02:01 binding "YLSPIASPL" at 2.51Å resolution |
5MEN |
HLA-A*02:01 presenting "ILAKFLHWL" to Alpha/Beta T cell receptor at 2.81Å resolution |
5MEQ |
HLA-A*02:01 binding "ILAKFLHTL" at 2.27Å resolution |
5IEK |
HLA-B*40:02 binding "REFSKEPEL" at 1.80Å resolution |
5IEH |
HLA-B*40:02 binding "REFSKEPEL" at 1.50Å resolution |
5MEP |
HLA-A*02:01 binding "ILGKFLHWL" at 2.71Å resolution |
5MER |
HLA-A*02:01 binding "ILAKFLHEL" at 1.88Å resolution |
5MEO |
HLA-A*02:01 binding "ILGKFLHRL" at 1.77Å resolution |
5F1I |
DLA-88*50801: binding "KLFSGELTK" at 2.90Å resolution |
5EUO |
HLA-A*02:01 presenting "GILGFVFTL" to Alpha/Beta T cell receptor at 2.10Å resolution |
5ENW |
HLA-A*02:01 binding "GLKEGIPAL" at 1.85Å resolution |
5E6I |
HLA-A*02:01 presenting "GILGFVFTL" to Alpha/Beta T cell receptor at 4.00Å resolution |
5IND |
HLA-B*58:11 binding "QASQDVKNW" at 2.13Å resolution |
5SWZ |
H2-Db presenting "ASNENMETM" to Alpha/Beta T cell receptor at 2.65Å resolution |
5INC |
HLA-B*58:11 binding "QATQEVKNW" at 2.88Å resolution |
5SWQ |
HLA-A*02:01 binding "CVNGSCFTV" at 2.00Å resolution |
5SWS |
H2-Db presenting "ASNENMETM" to Alpha/Beta T cell receptor at 2.86Å resolution |
5IM7 |
HLA-B*58:11 binding "QASQEVKNW" at 2.50Å resolution |
5IRO |
HLA-A*02:01 binding "LLFGYPVYV" with Human adenovirus type 4 E3-19K at 2.64Å resolution |
5H94 |
SLA-1*07:04 binding "KMNTQFTAV" at 1.48Å resolution |
4ZUU |
Eqca-N*006:01 binding "CTSEEMNAF" at 2.20Å resolution |
5B38 |
HLA-B*57:01 binding "LSSPVTKSF" with KIR-3 NK receptor at 2.30Å resolution |
5B39 |
HLA-B*57:01 binding "LSSPVTKSF" with KIR-3 NK receptor at 2.50Å resolution |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

This work is licensed under a Creative Commons Attribution 4.0 International License.